EUVIMEDEUVIMED entdecken
Open Access

Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score

Cameron D Thomas, Francesco Franchi, Joseph S Rossi, Ellen C Keeley, R David Anderson, Amber L Beitelshees, Julio D Duarte, Luis Ortega-Paz, Yan Gong, Richard A Kerensky, Natasha Kulick, Caitrin W McDonough und 10 weitere

Journal of the American College of Cardiology · 2024

DOI: 10.1016/j.jacc.2024.02.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American College of Cardiology, 2024. Verfasst von Cameron D Thomas und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of F…. Hauptthemen laut MEDLINE: Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NHGRI NIH HHS, NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: An ABCD-GENE (age, body mass index, chronic kidney disease, diabetes, and CYP2C19 genetic variants) score ≥10 predicts reduced clopidogrel effectiveness, but its association with response to alternative therapy remains unclear. OBJECTIVES: The aim of this study was to evaluate the association between ABCD-GENE score and the effectiveness of clopidogrel vs alternative P2Y12 inhibitor (prasugrel or ticagrelor) therapy after percutaneous coronary intervention (PCI). METHODS: A total of 4,335 patients who underwent PCI, CYP2C19 genotyping, and P2Y12 inhibitor treatment were included. The primary outcome was major atherothrombotic events (MAE) within 1 year after PCI. Cox regression was performed to assess event risk in clopidogrel-treated (reference) vs alternatively treated patients, with stabilized inverse probability weights derived from exposure propensity scores after stratifying by ABCD-GENE score and further by CYP2C19 loss-of-function (LOF) genotype. RESULTS: Among patients with scores

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet Aggregation InhibitorsPercutaneous Coronary InterventionHumansClopidogrelCytochrome P-450 CYP2C19TicagrelorTreatment OutcomeGenotype

Stichwörter der Autor:innen

CYP2C19clopidogrelgenetic testingpercutaneous coronary interventionprecision medicine

Substanzen

ClopidogrelPlatelet Aggregation InhibitorsCytochrome P-450 CYP2C19Ticagrelor

Autor:innen und Institutionen

  • Department of Pharmacotherapy and Translational Research and Center for Pharmacogenomics and Precision Medicine, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
  • Division of Cardiology, Department of Medicine, College of Medicine-Jacksonville, University of Florida, Jacksonville, Florida, USA.
  • Division of Cardiology and McAllister Heart Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
  • Division of Cardiovascular Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.
  • Department of Medicine and Program for Personalized and Genomic Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Division of Cardiology and McAllister Heart Institute, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA; Division of Pharmacotherapy and Experimental Therapeutics, Eshelm…

Förderung

  • NHLBI NIH HHS
  • NHGRI NIH HHS
  • NHLBI
  • NHGRI

Zitieren

APA

Thomas, C. D., Franchi, F., Rossi, J. S., Keeley, E. C., Anderson, R. D., Beitelshees, A. L., Duarte, J. D., Ortega-Paz, L., Gong, Y., Kerensky, R. A., Kulick, N., McDonough, C. W., Nguyen, A. B., Wang, Y., Winget, M., Yang, W. E., Johnson, J. A., Winterstein, A. G., Stouffer, G. A., …, & Cavallari, L. H. (2024). Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.02.015

Vancouver

Thomas CD, Franchi F, Rossi JS, Keeley EC, Anderson RD, Beitelshees AL, et al. Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score. Journal of the American College of Cardiology. 2024. doi:10.1016/j.jacc.2024.02.015

BibTeX
@article{Thomas2024,
  author = {Thomas, Cameron D and Franchi, Francesco and Rossi, Joseph S and Keeley, Ellen C and Anderson, R David and Beitelshees, Amber L and Duarte, Julio D and Ortega-Paz, Luis and Gong, Yan and Kerensky, Richard A and Kulick, Natasha and McDonough, Caitrin W and Nguyen, Anh B and Wang, Yehua and Winget, Marshall and Yang, William E and Johnson, Julie A and Winterstein, Almut G and Stouffer, George A and Angiolillo, Dominick J and Lee, Craig R and Cavallari, Larisa H},
  title = {Effectiveness of Clopidogrel vs Alternative P2Y12 Inhibitors Based on the ABCD-GENE Score},
  journal = {Journal of the American College of Cardiology},
  year = {2024},
  doi = {10.1016/j.jacc.2024.02.015}
}
Kostenlos starten →